Knight Therapeutics (FRA:04K) Operating Cash Flow per Share : €0.42 (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Operating Cash Flow per Share?

Knight Therapeutics's operating cash flow per share for the three months ended in Mar. 2024 was €0.21. Knight Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.42.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Knight Therapeutics was 91.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Knight Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

During the past 11 years, Knight Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 128.20% per year. The lowest was -35.30% per year. And the median was 127.10% per year.

FRA:04K's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 6.9
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Knight Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Knight Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Knight Therapeutics Operating Cash Flow per Share Chart

Knight Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

0.02

-0.06

0.25

0.27

0.23

Knight Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															0.03	-0.01	0.10	0.12	0.21

Competitive Comparison of Knight Therapeutics's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Knight Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Knight Therapeutics's Price-to-Operating-Cash-Flow falls into.

Knight Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Knight Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	24.565	/	107.466
	=	0.23

Knight Therapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	20.989	/	101.173
	=	0.21

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.42

Knight Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Knight Therapeutics (FRA:04K) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (FRA:04K) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

KHTRF:USA GUD:Canada

Address

3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8

Website

https://www.gud-knight.com

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.

Knight Therapeutics (FRA:04K) Headlines

No Headlines